These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1703241)
1. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). Morgan WR; Zincke H; Rainwater LM; Myers RP; Klee GG J Urol; 1991 Feb; 145(2):319-23. PubMed ID: 1703241 [TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome. Cheng WS; Bergstralh EJ; Frydenberg M; Zincke H Eur Urol; 1994; 25(3):189-93. PubMed ID: 7515348 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. Link P; Freiha FS; Stamey TA J Urol; 1991 Mar; 145(3):532-4. PubMed ID: 1705294 [TBL] [Abstract][Full Text] [Related]
4. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. Zincke H; Utz DC; Taylor WF J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572 [TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795 [TBL] [Abstract][Full Text] [Related]
8. Re: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). Fosså JD; Dearnaley DP J Urol; 1992 Jan; 147(1):173-4. PubMed ID: 1370328 [No Abstract] [Full Text] [Related]
9. The value of serum prostate specific antigen determinations before and after radical prostatectomy. Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013 [TBL] [Abstract][Full Text] [Related]
10. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. Zincke H Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377 [TBL] [Abstract][Full Text] [Related]
11. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439 [TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. Stamey TA; Kabalin JN; Ferrari M; Yang N J Urol; 1989 May; 141(5):1088-90. PubMed ID: 2468797 [TBL] [Abstract][Full Text] [Related]
13. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Salomon L; Levrel O; Anastasiadis AG; Saint F; de La Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC Prostate Cancer Prostatic Dis; 2002; 5(4):285-90. PubMed ID: 12627213 [TBL] [Abstract][Full Text] [Related]
14. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment. Zincke H NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496 [TBL] [Abstract][Full Text] [Related]
15. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300 [TBL] [Abstract][Full Text] [Related]
16. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. Zincke H; Lau W; Bergstralh E; Blute ML J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737 [TBL] [Abstract][Full Text] [Related]
17. [Management of prostate cancer in Senegal: what is being done?]. Niang L; Ndoye M; Ouattara A; Jalloh M; Labou M; Thiam I; Kouka SC; Diaw JJ; Gueye SM Prog Urol; 2013 Jan; 23(1):36-41. PubMed ID: 23287482 [TBL] [Abstract][Full Text] [Related]
18. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup. Myers RP; Larson-Keller JJ; Bergstralh EJ; Zincke H; Oesterling JE; Lieber MM J Urol; 1992 Mar; 147(3 Pt 2):910-5. PubMed ID: 1538495 [TBL] [Abstract][Full Text] [Related]
19. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
20. Observations on surgical management of carcinoma of prostate with limited nodal metastases. Zincke H; Utz DC Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]